Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Jeff Craven

    News

    Remote electrical neuromodulation device helps reduce migraine days

    Author:
    Jeff Craven

    The device decreased the number of migraine days by an average of 4 days per month.

    • Read More

    News

    Brepocitinib improves symptoms of mild to moderate AD in phase 2b trial

    Author:
    Jeff Craven
    Publish date: November 28, 2022

    In addition to AD, brepocitinib is currently being developed as a treatment for dermatomyositis, systemic lupus erythematosus, hidradenitis...

    • Read More

    News

    ICD-10 code can identify patients with melasma for future study

    Author:
    Jeff Craven
    Publish date: November 10, 2022

    “Overall, our results support the validity of using the ICD-10 code for melasma to identify patients with a diagnosis of melasma for future...

    • Read More

    News

    Immediate skin-to-skin contact after cesarean section improves outcomes for parent, newborn

    Author:
    Jeff Craven
    Publish date: October 25, 2022

    “One of the greatest take-home points from the study was that early skin-to-skin really promoted initiation of breastfeeding.”

    • Read More

    News

    Health care providers should have higher suspicion for rare diseases

    Author:
    Jeff Craven
    Publish date: October 15, 2022

    Learning to recognize when a cluster of symptoms doesn’t fit a pattern is important, as patients and their providers tend to gravitate toward...

    • Read More

    News

    Headache for inpatients with COVID-19 may predict better survival

    Author:
    Jeff Craven
    Publish date: October 13, 2022

    Headache arising secondary to COVID-19 infection may be a marker of enhanced likelihood of survival.

    • Read More

    News

    Body-brain neuroinflammation loop may cause chronic ME/CFS, long COVID symptoms

    Author:
    Jeff Craven

    ME/CSF and long COVID are biologically based and involve ‘much disturbed physiology.’

    • Read More

    News

    Large study reaffirms rare risk of TNF inhibitor–induced psoriasis in patients with RA, IBD

    Author:
    Jeff Craven
    Publish date: July 11, 2022

    Compared with conventional treatment, the risk of developing nonpustular psoriasis was twofold higher among patients receiving TNFi treatment.

    • Read More

    News

    Therapeutic patient education can help with adherence to treatment

    Author:
    Jeff Craven
    Publish date: June 9, 2022

    Therapeutic patient education is recommended for children and adults with moderate to severe AD in the 2020 European Task Force on Atopic...

    • Read More

    News

    Steroid phobia drives weaker prescribing, nonadherence for AD

    Author:
    Jeff Craven
    Publish date: May 9, 2022

    The source of these fears can be information from friends, relatives, media, the Internet, as well as doctors.

    • Read More

    News

    Repurposed drug could revolutionize stem cell transplantation

    Author:
    Jeff Craven
    Publish date: March 18, 2022

    Abatacept to prevent for acute graft-versus-host disease is a game changer for patients receiving hematopoietic stem cell transplants who lack...

    • Read More

    News

    Early treatment may delay atherosclerosis in familial hypercholesterolemia

    Author:
    Jeff Craven
    Publish date: March 7, 2022

    Cholesterol-lowering treatment early in life appeared to slow intima-media growth in a meta-analysis.

    • Read More

    News

    Health disparities exist all over rheumatology: What can be done?

    Author:
    Jeff Craven
    Publish date: February 28, 2022

    Health equity should be a “desirable goal” for patients who experience health disparities, but it needs to be a “continuous effort,” said Dr....

    • Read More

    News

    Rheumatology patients seek guidance on CBD, cannabis products

    Author:
    Jeff Craven
    Publish date: February 25, 2022

    Dr. Orrin Troum suggests putting away any personal biases you may have to learn how to best advise patients who are using or considering using...

    • Read More

    News

    Treat-to-target in RA: Questions remain about adoption, measurement

    Author:
    Jeff Craven
    Publish date: February 22, 2022

    Rheumatologists Jack Cush and Martin Bergman debate the value of using a treat-to-target approach in managing patients with RA, focusing on...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery